AI News, Artificial Intelligence can diagnose a brain tumor in just two minutes ... artificial intelligence
- On 11. februar 2020
- By Read More
Artificial intelligence in healthcare
Artificial intelligence (AI) in healthcare is the use of complex algorithms and software to emulate human cognition in the analysis of complicated medical data.
What distinguishes AI technology from traditional technologies in health care is the ability to gain information, process it and give a well-defined output to the end-user.
AI algorithms behave differently from humans in two ways: (1) algorithms are literal: if you set a goal, the algorithm can't adjust itself and only understand what it has been told explicitly, (2) and algorithms are black boxes;
AI programs have been developed and applied to practices such as diagnosis processes, treatment protocol development, drug development, personalized medicine, and patient monitoring and care.
to support operational initiatives that increase cost saving, improve patient satisfaction, and satisfy their staffing and workforce needs.
that help healthcare managers improve business operations through increasing utilization, decreasing patient boarding, reducing length of stay and optimizing staffing levels.
During this time, there was a recognition by researchers and developers that AI systems in healthcare must be designed to accommodate the absence of perfect data and build on the expertise of physicians.
The ability to interpret imaging results with radiology may aid clinicians in detecting a minute change in an image that a clinician might accidentally miss.
A study at Stanford created an algorithm that could detect pneumonia at that specific site, in those patients involved, with a better average F1 metric (a statistical metric based on accuracy and recall), than the radiologists involved in that trial.
The emergence of AI technology in radiology is perceived as a threat by some specialists, as the technology can achieve improvements in certain statistical metrics in isolated cases, as opposed to specialists.
Recent advances have suggested the use of AI to describe and evaluate the outcome of maxillo-facial surgery or the assessment of cleft palate therapy in regard to facial attractiveness or age appearance.
In 2018, a paper published in the journal Annals of Oncology mentioned that skin cancer could be detected more accurately by an artificial intelligence system (which used a deep learning convolutional neural network) than by dermatologists.
One study conducted by the Centerstone research institute found that predictive modeling of EHR data has achieved 70–72% accuracy in predicting individualized treatment response at baseline.
To address the difficulty of tracking all known or suspected drug-drug interactions, machine learning algorithms have been created to extract information on interacting drugs and their possible effects from medical literature.
Efforts were consolidated in 2013 in the DDIExtraction Challenge, in which a team of researchers at Carlos III University assembled a corpus of literature on drug-drug interactions to form a standardized test for such algorithms.
Other algorithms identify drug-drug interactions from patterns in user-generated content, especially electronic health records and/or adverse event reports.
DSP-1181, a molecule of the drug for OCD (obsessive-compulsive disorder) treatment, was invented by artificial intelligence through joint efforts of Exscientia (British start-up) and Sumitomo Dainippon Pharma (Japanese pharmaceutical firm).
The drug development took a single year, while pharmaceutical companies usually spend about five years on similar projects.
The subsequent motive of large based health companies merging with other health companies, allow for greater health data accessibility.
A second project with the NHS involves analysis of medical images collected from NHS patients to develop computer vision algorithms to detect cancerous tissues.
Intel's venture capital arm Intel Capital recently invested in startup Lumiata which uses AI to identify at-risk patients and develop care options.
team associated with the University of Arizona and backed by BPU Holdings began collaborating on a practical tool to monitor anxiety and delirium in hospital patients, particularly those with Dementia.
The AI utilized in the new technology – Senior's Virtual Assistant – goes a step beyond and is programmed to simulate and understand human emotions (artificial emotional intelligence).
Doctors working on the project have suggested that in addition to judging emotional states, the application can be used to provide companionship to patients in the form of small talk, soothing music, and even lighting adjustments to control anxiety.
Virtual nursing assistants are predicted to become more common and these will use AI to answer patient's questions and help reduce unnecessary hospital visits.
Overall, as Quan-Haase (2018) says, technology “extends to the accomplishment of societal goals, including higher levels of security, better means of communication over time and space, improved health care, and increased autonomy” (p. 43).
While research on the use of AI in healthcare aims to validate its efficacy in improving patient outcomes before its broader adoption, its use may nonetheless introduce several new types of risk to patients and healthcare providers, such as algorithmic bias, Do not resuscitate implications, and other machine morality issues.
We already have some scientists who know artificial intelligence and machine learning, but we want complementary people who can look forward and see how this technology will evolve.”
As of November 2018, eight use cases are being benchmarked, including assessing breast cancer risk from histopathological imagery, guiding anti-venom selection from snake images, and diagnosing skin lesions.
- On 24. september 2021
Doctors hope new AI technology will better identify brain tumors
Researchers aim to use artificial intelligence technology to perform "virtual biopsies" to help identify a tumor without surgery. CBS Boston's Dr. Mallika Marshall ...
AI defeats doctors in neuro imaging competition
(5 Jul 2018) LEADIN Artifical Intelligence has defeated a group of human doctors in a neuroimaging competition in Beijing. In two rounds of competition, ...
New blood test detects brain tumors with 87% accuracy
A new blood test that can detect brain cancer has been developed in the United Kingdom. It's cutting edge technology uses artificial intelligence and has a high ...
An Artificial Intelligence Approach to Lung Cancer Early Diagnosis, Peng Huang, PhD
Dr. Huang's research mainly focuses on global assessment of treatment effect when multiple endpoints are evaluated simultaneously. This includes optimal ...
Machine Learning For Medical Image Analysis - How It Works
Machine learning can greatly improve a clinician's ability to deliver medical care. This JAMA video talks to Google scientists and clinical methodologists to ...
Aether AI - Medical Image Multi-Class Segmentation - Brain MRI
This is a sneak preview of Aether AI medical imaging software. A human brain MRI is segmented into 8 classes with unprecedented accuracy, each class ...
How doctors can help AI to revolutionize medicine
Greg Corrado, Co-founder of Google Brain and Principal Scientist at Google, has spent the last decade at the forefront of the AI revolution. Greg's vision for how ...
IBM researchers bring AI to radiology
With advances in machine learning and artifiical intelligence, a new role is emerging for machines as intelligent assistants for radiologists in their clinical work ...
CardioAI: Automated Medical Diagnosis from MRI and Patient Data Using Deep Learning with Ivo Everts
In order to alleviate medical staff from time consuming manual labour, GoDataDriven and the cardiovascular department of the University Medical Center ...
Google's AI can now detect Cardiovascular risks from Retinal scans
This research has been carried out by Google Brain. Images shown are for intuition purpose only. Not actual images of the experiment.